Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Interest Expenses: 2010-2024

Historic Interest Expenses for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to $27,353.

  • China Pharma Holdings' Interest Expenses fell 0.66% to $6,798 in Q3 2025 from the same period last year, while for Sep 2025 it was $27,166, marking a year-over-year increase of 111.70%. This contributed to the annual value of $27,353 for FY2024, which is 10.53% down from last year.
  • China Pharma Holdings' Interest Expenses amounted to $27,353 in FY2024, which was down 10.53% from $30,572 recorded in FY2023.
  • In the past 5 years, China Pharma Holdings' Interest Expenses ranged from a high of $542,001 in FY2021 and a low of $27,353 during FY2024.
  • Over the past 3 years, China Pharma Holdings' median Interest Expenses value was $30,572 (recorded in 2023), while the average stood at $164,181.
  • Its Interest Expenses has fluctuated over the past 5 years, first spiked by 84.25% in 2021, then slumped by 92.97% in 2023.
  • China Pharma Holdings' Interest Expenses (Yearly) stood at $294,159 in 2020, then surged by 84.25% to $542,001 in 2021, then decreased by 19.81% to $434,619 in 2022, then slumped by 92.97% to $30,572 in 2023, then declined by 10.53% to $27,353 in 2024.